TR200001799T2 - Müstahzar olarak 5-(4-(2-(n-metil-n-(2-pirildil) mino)etoksi)benzil) tiyazolidin,-2,4-diyon, maleik asit tuzu, hidratı. - Google Patents

Müstahzar olarak 5-(4-(2-(n-metil-n-(2-pirildil) mino)etoksi)benzil) tiyazolidin,-2,4-diyon, maleik asit tuzu, hidratı.

Info

Publication number
TR200001799T2
TR200001799T2 TR2000/01799T TR200001799T TR200001799T2 TR 200001799 T2 TR200001799 T2 TR 200001799T2 TR 2000/01799 T TR2000/01799 T TR 2000/01799T TR 200001799 T TR200001799 T TR 200001799T TR 200001799 T2 TR200001799 T2 TR 200001799T2
Authority
TR
Turkey
Prior art keywords
thiazolidine
dione
pyridyl
ethoxy
benzyl
Prior art date
Application number
TR2000/01799T
Other languages
English (en)
Turkish (tr)
Inventor
David James Blackler Paul
C. Lee David
John Sasse Michael
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of TR200001799T2 publication Critical patent/TR200001799T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TR2000/01799T 1997-12-16 1998-12-14 Müstahzar olarak 5-(4-(2-(n-metil-n-(2-pirildil) mino)etoksi)benzil) tiyazolidin,-2,4-diyon, maleik asit tuzu, hidratı. TR200001799T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9726566.4A GB9726566D0 (en) 1997-12-16 1997-12-16 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
TR200001799T2 true TR200001799T2 (tr) 2001-01-22

Family

ID=10823692

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2000/01799T TR200001799T2 (tr) 1997-12-16 1998-12-14 Müstahzar olarak 5-(4-(2-(n-metil-n-(2-pirildil) mino)etoksi)benzil) tiyazolidin,-2,4-diyon, maleik asit tuzu, hidratı.
TR1998/02625A TR199802625A3 (tr) 1997-12-16 1998-12-16 Yeni farmasötikler

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR1998/02625A TR199802625A3 (tr) 1997-12-16 1998-12-16 Yeni farmasötikler

Country Status (35)

Country Link
EP (2) EP1661895A1 (2)
JP (1) JP2002508373A (2)
KR (1) KR100549142B1 (2)
CN (3) CN1281453A (2)
AP (1) AP1365A (2)
AR (1) AR017214A1 (2)
AU (1) AU1967999A (2)
BG (1) BG64988B1 (2)
BR (1) BR9813600A (2)
CA (1) CA2314107A1 (2)
CO (1) CO4980880A1 (2)
CZ (1) CZ299965B6 (2)
DZ (1) DZ2681A1 (2)
EA (1) EA004260B1 (2)
EG (1) EG22337A (2)
GB (1) GB9726566D0 (2)
HR (1) HRP20000408B1 (2)
HU (1) HUP0100509A3 (2)
IL (1) IL136424A (2)
IN (1) IN192487B (2)
MA (1) MA26580A1 (2)
MY (1) MY135612A (2)
NO (1) NO317254B1 (2)
OA (1) OA11766A (2)
PE (1) PE20000058A1 (2)
PL (1) PL341146A1 (2)
RS (1) RS50126B (2)
SA (1) SA99191115B1 (2)
SK (1) SK286618B6 (2)
TR (2) TR200001799T2 (2)
TW (1) TW509690B (2)
UA (1) UA72198C2 (2)
UY (2) UY25308A1 (2)
WO (1) WO1999031095A1 (2)
ZA (1) ZA9811506B (2)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
PL351684A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
AU765498B2 (en) * 1999-04-23 2003-09-18 Smithkline Beecham Plc Novel pharmaceutical
HK1045152A1 (zh) * 1999-04-23 2002-11-15 Smithkline Beecham Plc 噻唑烷二酮衍生物及其用作抗糖尿病藥的應用
HUP0300475A3 (en) * 2000-04-25 2004-10-28 Kyorin Seiyaku Kk Novel stable crystal of thiazolidinedione derivative and process for producing the same
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
AU2001291232B8 (en) * 2000-09-26 2006-12-21 Dr. Reddy's Laboratories Limited Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
MXPA03002580A (es) * 2000-09-26 2003-10-15 Cord Janet I Nuevas formas polimorficas de maleato de 5-(4-(2-(n-metil-n-(2-piridil) amino)etoxi)bencil) tiazolidin-2, 4-diona y proceso para su preparacion.
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
JPH09512249A (ja) * 1994-02-10 1997-12-09 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 腎臓疾患を治療するためのインスリンセンシタイザーの使用

Also Published As

Publication number Publication date
AP2000001831A0 (en) 2000-06-30
ZA9811506B (en) 2000-11-06
RS50126B (sr) 2009-03-25
CN101302215A (zh) 2008-11-12
CZ299965B6 (cs) 2009-01-07
CZ20002204A3 (cs) 2000-11-15
SK286618B6 (sk) 2009-02-05
BG104603A (en) 2001-03-30
HRP20000408B1 (hr) 2008-04-30
AU1967999A (en) 1999-07-05
GB9726566D0 (en) 1998-02-11
IN192487B (2) 2004-04-24
BR9813600A (pt) 2000-10-10
SA99191115B1 (ar) 2006-10-11
IL136424A0 (en) 2001-06-14
UY25308A1 (es) 1999-07-19
HUP0100509A3 (en) 2002-06-28
EG22337A (en) 2002-12-31
SK9172000A3 (en) 2001-01-18
CN1281453A (zh) 2001-01-24
PE20000058A1 (es) 2000-02-26
YU36300A (sh) 2004-03-12
MY135612A (en) 2008-05-30
TW509690B (en) 2002-11-11
TR199802625A2 (xx) 1999-10-21
CA2314107A1 (en) 1999-06-24
OA11766A (en) 2005-07-19
NO317254B1 (no) 2004-09-27
AR017214A1 (es) 2001-08-22
EA004260B1 (ru) 2004-02-26
MA26580A1 (fr) 2004-12-20
UA72198C2 (en) 2005-02-15
NO20003069D0 (no) 2000-06-15
KR20010033141A (ko) 2001-04-25
IL136424A (en) 2003-12-10
CO4980880A1 (es) 2000-11-27
KR100549142B1 (ko) 2006-02-03
EP1661895A1 (en) 2006-05-31
AP1365A (en) 2005-01-26
HUP0100509A2 (hu) 2002-05-29
BG64988B1 (bg) 2006-11-30
NO20003069L (no) 2000-06-15
PL341146A1 (en) 2001-03-26
CN101381367A (zh) 2009-03-11
TR199802625A3 (tr) 1999-10-21
JP2002508373A (ja) 2002-03-19
WO1999031095A1 (en) 1999-06-24
HRP20000408A2 (en) 2000-08-31
EP1040110A1 (en) 2000-10-04
EA200000654A1 (ru) 2000-12-25
DZ2681A1 (fr) 2004-06-20
UY25304A1 (es) 2000-12-29

Similar Documents

Publication Publication Date Title
TR200001793T2 (tr) Yapısında değişiklik yapılmış tiyazolidinediyon türevi, bunun hazırlanması için işlem ve eczacılık alanında kullanımı
ES2133543T3 (es) Derivados de pirrolidina y oxazolidina, su preparacion y su uso como inhibidores de la agregacion de trombocitos.
TR199901667T2 (xx) 3-Heterosiklil-ikame edilmi� benzoil t�revleri
TR200001798T2 (tr) 5-(4-(2-(N-metil-N-(2-piridil) amino)oksi)benzil) tiyazolidin-2'nin hidratı, 4-diyon maleik asit tuzu.
CA2297911A1 (en) Substituted 6-phenylphenanthridines
ATE330955T1 (de) Indolderivate und deren verwendung als inhibitoren der phosphodiesterase 4.
BG103590A (en) Pesticide 1-arylpyrazols
NL350045I1 (nl) N-(5,7-dimethoxy\[1,2,4\]triazolo\[1,5-a\]pyrimidin-2-yl)arylsulfonamideverbindingen en het gebruik ervan als herbiciden.
BG104670A (en) 4-(2-keto-1-benzimidazolinyl)piperidinne compounds as orl1-receptor agonists
ATE260899T1 (de) Neue tetrazolderivate
GR3015313T3 (en) Indole derivatives as antiallergy and antiinflammatory agents.
CA2250569A1 (en) Novel phenanthridines substituted in the 6 position
ATE429450T1 (de) Chimärische dr4 antikörper und ihre verwendung
BR9711134A (pt) Composto e uso de um composto
MY124487A (en) Dolastatin derivatives, their preparation and use
DE50301941D1 (de) Derivate-1h-pyrazolo (3, 4-b) -5-(4-pyridinyl)-4-pyrimidinamins und ihre verwendung als guanylatcyclase-stimulatoren
ATE323686T1 (de) Substituierte 2-arylbenzazole und ihre verwendung als antitumorale mittel
WO2001055066A3 (en) 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicides
HRP20000408B1 (hr) 5-/4-/2-(n-metil-n-(2-piridil)amino)etoksi/benzil/tiazolidin-2,4-dion, sol maleinske kiseline, hidrat kao farmaceutik
DE69821530D1 (de) Dihydrobenzifurane
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
MXPA03003923A (es) Compuestos de n-([1,2,4]triazoloazinil)tiofensulfonamida como herbicidas.
ES2002352A6 (es) Procedimiento para la preparacion de 3,4,5,6-tetrahidroftalimidas substituidas en n.
TR199901416T2 (xx) Heterosiklik karbonikasit t�revleri.
CA2423357A1 (en) Fused heterocyclic derivatives as phosphodiesterase inhibitors